PER 0.00% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-33

  1. 3,236 Posts.
    lightbulb Created with Sketch. 275
    Hi KP
    I gave you thumbs up but not in full.
    I agree with you but not in full. I agree that, looking at the past, there is huge risk that the money
    coming in are 2rd ( or the majority as shown in last financial report) are spent in Diamond'salary
    and some other expenses as a consequence of his and other directors' activities.
    What I do not agree is the fact you should look this operation from a different angle which is the fact
    that to get that 20% someone is ready to pay up, Australian Ethics investments, and in my view
    I refuse (hope) to think that out there exist someone ready to invest a considerable amount of money
    without the intention to make of profit out of that. That 20% "given away" as you say will give
    existing share older a better sp by 10% - 20% - 30%....................80.......% .????? Nothing ?
    We do not know right ? Well you have to admit that there is a possibility right ? Therefore it is
    a positive news not a total disaster like someone wants to put it.
    Once in a while: Give to Caesar what is Caesar's........
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 7.9¢ $142.6K 1.782M

Buyers (Bids)

No. Vol. Price($)
1 100000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 1335 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.